The common GCKR variant has a more pronounced effect on hepatic fat accumulation and plasma triacylglycerols in individuals with obesity (Simons et al., 2016; Stender et al., 2017) and hyperglycaemia. Here, GCKR is linked to obesity due to melanocortin 4 receptor deficiency.